APW
ALXN

Acima Private Wealth’s Alexion Pharmaceuticals ALXN Stock Holding History

Acima Private Wealth’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-37
Closed -$7K – 239
2021
Q2 		$7K Hold
37
– – ﹤0.01% 213
2021
Q1 		$6K Hold
37
– – ﹤0.01% 214
2020
Q4 		$6K Sell
37
-31
-46% -$3.98K ﹤0.01% 216
2020
Q3 		$8K Hold
68
– – ﹤0.01% 198
2020
Q2 		$8K Hold
68
– – 0.01% 217
2020
Q1 		$6K Hold
68
– – ﹤0.01% 235
2019
Q4 		$7K Hold
68
– – ﹤0.01% 250
2019
Q3 		$6K Hold
68
– – ﹤0.01% 241
2019
Q2 		$9K Hold
68
– – 0.01% 211
2019
Q1 		$9K Sell
68
-6
-8% -$746 0.01% 211
2018
Q4 		$7K Buy
+74
New +$8.75K 0.01% 221

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return